Silo Pharma, Inc. — Major Shareholding Notification 2021

Jan 19, 2021

SC 13G/A 1 ea133576-13ga5alpha_silophar.htm AMENDMENT NO. 5 TO SCHEDULE 13G

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(AMENDMENT NO. 5)

SILO PHARMA, INC.

Field: Rule-Page

Field: /Rule-Page

(Name of Issuer)

COMMON STOCK, $.0001 PAR VALUE

Field: Rule-Page

Field: /Rule-Page

(Title of Class of Securities)

82711P102

Field: Rule-Page

Field: /Rule-Page

(CUSIP Number)

December 31, 2019

Field: Rule-Page

Field: /Rule-Page

(DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(c)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following page(s)

Page 1 of 5 Pages

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CUSIP No. 82711P102 13G Page 2 of 5 Pages

1. NAMES OF REPORTING PERSON

S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Alpha Capital Anstalt

Field: Rule-Page

Field: /Rule-Page

1. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:

(a) ☐

(b) ☐

Field: Rule-Page

Field: /Rule-Page

1. SEC USE ONLY

Field: Rule-Page

Field: /Rule-Page

1. CITIZENSHIP OR PLACE OF ORGANIZATION

Liechtenstein

Field: Rule-Page

Field: /Rule-Page

1. SOLE VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON – 4,027,011 Shares of Common Stock (1)

Field: Rule-Page

Field: /Rule-Page

1. SHARED VOTING POWER – None

Field: Rule-Page

Field: /Rule-Page

1. SOLE DISPOSITIVE POWER – 4,027,011 Shares of Common Stock (1)

Field: Rule-Page

Field: /Rule-Page

1. SHARED DISPOSITIVE POWER – None

Field: Rule-Page

Field: /Rule-Page

1. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON – 4,027,011 Shares of Common Stock (1)

Field: Rule-Page

Field: /Rule-Page

1. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

Field: Rule-Page

Field: /Rule-Page

1. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

4.73% (1)

Field: Rule-Page

Field: /Rule-Page

1. TYPE OF REPORTING PERSON

CO

Field: Rule-Page

Field: /Rule-Page

(1) Based on 85,141,956 shares outstanding as of November 4, 2020 as reported on Form 10-Q filed on November 5, 2020.

Field: Page; Sequence: 2

Field: /Page

CUSIP No. 82711P102 13G Page 3 of 5 Pages

ITEM 1 (a) NAME OF ISSUER: Silo Pharma Inc., a New York corporation

ITEM 1 (b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

285 Grand Avenue, Building 5, Englewood, NJ 07631

ITEM 2 (a) NAME OF PERSON FILING: Alpha Capital Anstalt

ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

Lettstrasse 32, FL-9490 Vaduz, Furstentums, Liechtenstein

ITEM 2 (c) CITIZENSHIP: Liechtenstein

ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Stock, $.0001 par value

ITEM 2 (e) CUSIP NUMBER: 82711P102

ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B): Not applicable

ITEM 4 OWNERSHIP

(a) AMOUNT BENEFICIALLY OWNED: 4,027,011 Shares of Common Stock (1)

(b) PERCENT OF CLASS: 4.73% (1)

(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:

(i) SOLE POWER TO VOTE OR DIRECT THE VOTE

4,027,011 Shares of Common Stock (1)

(ii) SHARED POWER TO VOTE OR DIRECT THE VOTE

0 Shares

(iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

4,027,011 Shares of Common Stock (1)

(iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

0 Shares

Field: Page; Sequence: 3

Field: /Page

CUSIP No. 82711P102 13G Page 4 of 5 Pages

ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

Alpha Capital Anstalt’s ownership is now below 5%.

ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

Not applicable

ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable

ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP

Not applicable

ITEM 9 NOTICE OF DISSOLUTION OF GROUP

Not applicable

Field: Page; Sequence: 4

Field: /Page

CUSIP No. 82711P102 13G Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

January 19, 2021
(Date)
/s/ Konrad Ackerman
(Signature)
Konrad Ackerman, Director
(Name/Title)

Field: Page; Sequence: 5

Field: /Page